What is it about?

We have shown that routine genetic testing of patients with hypertrophic cardiomyopathy allows us to identify patients who require specific treatment and patients who are at greater risk of an unfavorable course of heart failure.

Featured Image

Read the Original

This page is a summary of: Hypertrophic Cardiomyopathy in Underrepresented Populations: Clinical and Genetic Landscape Based on a Russian Single-Center Cohort Study, Genes, November 2023, MDPI AG,
DOI: 10.3390/genes14112042.
You can read the full text:

Read

Contributors

The following have contributed to this page